AMOXICILLIN Drug Patent Profile
When do Amoxicillin patents expire, and what generic alternatives are available?
Amoxicillin is a drug marketed by Aurobindo, Chartwell, Chartwell Rx, Hikma Pharms, Labs Atral, Micro Labs, Mylan, Sandoz, Strides Pharma Intl, Sun Pharm Inds Ltd, Teva, Aurobindo Pharma Ltd, Hikma, Ph Health, Apothecon, Aurobindo Pharma, Cipla, Deva Holding As, Micro Labs Ltd India, Sandoz Inc, Apotex Inc, and Regcon Holdings. and is included in eighty-five NDAs.
The generic ingredient in AMOXICILLIN is amoxicillin; clavulanate potassium. There are two drug master file entries for this compound. Thirty-three suppliers are listed for this compound. Additional details are available on the amoxicillin; clavulanate potassium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Amoxicillin
A generic version of AMOXICILLIN was approved as amoxicillin; clavulanate potassium by SANDOZ on March 14th, 2002.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for AMOXICILLIN?
- What are the global sales for AMOXICILLIN?
- What is Average Wholesale Price for AMOXICILLIN?
Summary for AMOXICILLIN
| US Patents: | 0 |
| Applicants: | 22 |
| NDAs: | 85 |
| Finished Product Suppliers / Packagers: | 36 |
| Raw Ingredient (Bulk) Api Vendors: | 66 |
| Clinical Trials: | 680 |
| Patent Applications: | 4,733 |
| Drug Prices: | Drug price information for AMOXICILLIN |
| Drug Sales Revenues: | Drug sales revenues for AMOXICILLIN |
| What excipients (inactive ingredients) are in AMOXICILLIN? | AMOXICILLIN excipients list |
| DailyMed Link: | AMOXICILLIN at DailyMed |
Recent Clinical Trials for AMOXICILLIN
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Yantai Zhifu Hospital | NA |
| Agnaldo Rocha de Souza Junior | NA |
| Qilu Hospital of Shandong University | NA |
Pharmacology for AMOXICILLIN
| Drug Class | Penicillin-class Antibacterial |
Medical Subject Heading (MeSH) Categories for AMOXICILLIN
Anatomical Therapeutic Chemical (ATC) Classes for AMOXICILLIN
US Patents and Regulatory Information for AMOXICILLIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chartwell Rx | AMOXICILLIN | amoxicillin | TABLET;ORAL | 065344-001 | Jan 15, 2009 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Sandoz Inc | AMOXICILLIN AND CLAVULANATE POTASSIUM | amoxicillin; clavulanate potassium | FOR SUSPENSION;ORAL | 065358-001 | Aug 13, 2007 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Mylan | AMOXICILLIN | amoxicillin | FOR SUSPENSION;ORAL | 062090-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Chartwell Rx | AMOXICILLIN | amoxicillin | FOR SUSPENSION;ORAL | 061931-002 | Approved Prior to Jan 1, 1982 | AB | RX | No | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
